United States · FDA National Drug Code directory

Travoprost

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
51407-731_44232930-266b-fec5-e063-6394a90a9184
Product NDC
51407-731
Form
SOLUTION
Composition / generic term
travoprost
Labeler
Golden State Medical Supply, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20150710
Source listing expiry
20261231

Source-listed ingredients

  • TRAVOPROST — .04 mg/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BOTTLE in 1 CARTON (51407-731-05) / 5 mL in 1 BOTTLE · 51407-731-05
  • 1 BOTTLE in 1 CARTON (51407-731-25) / 2.5 mL in 1 BOTTLE · 51407-731-25

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →